Target intelligence / Profile preview

Lysosomal acidic compartment

Molecular classification
Other
01

Overview

The lysosomal acidic compartment is a specialized membrane-bound organelle characterized by an internal pH of approximately 4.5 to 5.0, maintained by the vacuolar H+-ATPase (V-ATPase) proton pump [1]. This acidic environment is essential for the optimal activity of over 60 different acid hydrolases responsible for the degradation of proteins, lipids, and complex carbohydrates [2]. Beyond its role in waste disposal, the lysosome serves as a metabolic signaling hub, regulating autophagy and nutrient sensing through the recruitment of the mTORC1 complex [1]. In various diseases, such as cancer, the lysosomal compartment is often reorganized or enlarged to support increased metabolic demands, making it a vulnerable target for lysosomotropic drugs that can trigger lysosomal membrane permeabilization and subsequent cell death [4]. Pharmacologically, this compartment is targeted by weakly basic drugs, such as chloroquine and hydroxychloroquine, which accumulate within the lumen via "pH trapping" to neutralize the acidity or inhibit specific lysosomal functions [2]. This sequestration can interfere with viral entry, parasite survival (e.g., Plasmodium in malaria), and autophagic flux in tumor cells [3, 4].

Other names
LysosomeAcidic vacuoleLysosomal lumenAcidic organelle
02

Mechanism of action

Lysosomotropism (pH trapping), pH neutralization, inhibition of acid hydrolases, disruption of autophagic flux, lysosomal membrane permeabilization (LMP)

03

Biological functions

Protein degradationAutophagyNutrient sensingApoptosisIon homeostasisEndocytosisMetabolic signaling
04

Disease associations

CancerMalariaLysosomal storage diseaseNeurodegenerative diseaseViral infection (e.g., SARS-CoV-2)
05

Safety considerations

RetinopathyPhospholipidosisCardiotoxicitySystemic toxicity due to non-specific accumulationNeuromuscular toxicity
06

Interacting drugs

Chloroquine

6 more in the full profile.

07

Biomarkers

Lysosomal pHLAMP1 (Lysosome-associated membrane protein 1)Cathepsin B/D activityLysoTracker fluorescenceTFEB (Transcription Factor EB) nuclear translocation

Beyond the preview

Go deeper on Lysosomal acidic compartment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysosomal acidic compartment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call